Nocebos in rheumatology: emerging concepts and their implications for clinical practice
出版年份 2018 全文链接
标题
Nocebos in rheumatology: emerging concepts and their implications for clinical practice
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 14, Issue 12, Pages 727-740
出版商
Springer Nature America, Inc
发表日期
2018-10-26
DOI
10.1038/s41584-018-0110-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain
- (2018) Giacomo Rossettini et al. BMC MUSCULOSKELETAL DISORDERS
- Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study
- (2018) G. Girolomoni et al. BRITISH JOURNAL OF DERMATOLOGY
- The nocebo effect challenges the non-medical infliximab switch in practice
- (2018) N. W. Boone et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Does Googling lead to statin intolerance?
- (2018) Sarah Khan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Autonomic Arousal as a Mechanism of the Persistence of Nocebo Hyperalgesia
- (2018) Ben Colagiuri et al. JOURNAL OF PAIN
- Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
- (2018) B Glintborg et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Acceptance Rate And Sociological Factors Involved In The Switch From Originator To Biosimilar Etanercept (SB4)
- (2018) Marc Scherlinger et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France
- (2018) Jérôme Avouac et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- An Extension Study of PF-05280586, a Potential Rituximab Biosimilar, versus Rituximab in Subjects with Active Rheumatoid Arthritis
- (2018) Stanley B Cohen et al. ARTHRITIS CARE & RESEARCH
- Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
- (2018) Rishi J Desai et al. BMJ-British Medical Journal
- Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
- (2018) Rishi J Desai et al. BMJ-British Medical Journal
- Open-Label Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: 6-Month Results From a Controlled Cohort Study
- (2018) Lieke Tweehuysen et al. Arthritis & Rheumatology
- Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis
- (2018) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance
- (2017) Marc Scherlinger et al. JOINT BONE SPINE
- Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
- (2017) Ajay Gupta et al. LANCET
- Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
- (2017) Kristin K Jørgensen et al. LANCET
- Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
- (2017) Michael E. Wechsler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nocebo effects can make you feel pain
- (2017) Luana Colloca SCIENCE
- Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia
- (2017) A. Tinnermann et al. SCIENCE
- Influence of Morphine and Naloxone on Pain Modulation in Rheumatoid Arthritis, Chronic Fatigue Syndrome/Fibromyalgia, and Controls: A Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study
- (2017) Linda Hermans et al. Pain Practice
- Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid Arthritis
- (2017) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab
- (2017) Lieke Tweehuysen et al. Arthritis & Rheumatology
- A systematic review of sex differences in the placebo and the nocebo effect
- (2017) Sara Vambheim et al. Journal of Pain Research
- Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians
- (2016) Hillel Cohen et al. ADVANCES IN THERAPY
- Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials
- (2016) Kun Zou et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study
- (2016) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
- (2016) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study
- (2016) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis
- (2016) Stanley Cohen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Nocebo in headache
- (2016) Dimos D. Mitsikostas CURRENT OPINION IN NEUROLOGY
- Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases
- (2016) Stefano Gentileschi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
- (2016) Maurizio Benucci et al. IMMUNOLOGIC RESEARCH
- Lessons Learned From Nocebo Effects in Clinical Trials for Pain Conditions and Neurodegenerative Disorders
- (2016) Martina Amanzio et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn’s and Ulcerative Colitis Associations: Table 1.
- (2016) Laurent Peyrin-Biroulet et al. Journal of Crohns & Colitis
- Safety and efficacy of CT-P13 in Japanese patients with rheumatoid arthritis in an extension phase or after switching from infliximab
- (2016) Yoshiya Tanaka et al. Modern Rheumatology
- The power and value of placebo and nocebo in painful osteoarthritis
- (2016) P. Dieppe et al. OSTEOARTHRITIS AND CARTILAGE
- Pain facilitation and pain inhibition during conditioned pain modulation in fibromyalgia and in healthy controls
- (2016) Stéphane Potvin et al. PAIN
- Changes in perception of treatment efficacy are associated to the magnitude of the nocebo effect and to personality traits
- (2016) Nicole Corsi et al. Scientific Reports
- Effectiveness and Implications of Alternative Placebo Treatments
- (2015) Raveendhara R. Bannuru et al. ANNALS OF INTERNAL MEDICINE
- A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy
- (2015) Jung-Yoon Choe et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
- (2015) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3111, a Trastuzumab Biosimilar, and Trastuzumab in Healthy Japanese Adult Males: Results of a Randomized Trial
- (2015) Jun Morita et al. BIODRUGS
- Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data
- (2015) Elena Nikiphorou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Accentuate the positive: Counteracting psychogenic responses to media health messages in the age of the Internet
- (2015) Fiona Crichton et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain
- (2015) Wenjie Ren et al. NATURE NEUROSCIENCE
- Biosimilars in rheumatology: current perspectives and lessons learnt
- (2015) Thomas Dörner et al. Nature Reviews Rheumatology
- Neural underpinnings of nocebo hyperalgesia in visceral pain: A fMRI study in healthy volunteers
- (2015) Julia Schmid et al. NEUROIMAGE
- Distinct neural representations of placebo and nocebo effects
- (2015) Sonya Freeman et al. NEUROIMAGE
- Nociception, Pain, Negative Moods, and Behavior Selection
- (2015) Marwan N. Baliki et al. NEURON
- Touch inhibits subcortical and cortical nociceptive responses
- (2015) Flavia Mancini et al. PAIN
- Measuring nonspecific factors in treatment: item banks that assess the healthcare experience and attitudes from the patient’s perspective
- (2015) Carol M. Greco et al. QUALITY OF LIFE RESEARCH
- Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review
- (2015) Sarah Colgan et al. BMJ Open
- A Neural Mechanism for Nonconscious Activation of Conditioned Placebo and Nocebo Responses
- (2014) Karin B. Jensen et al. CEREBRAL CORTEX
- Pain anticipation: An activation likelihood estimation meta-analysis of brain imaging studies
- (2014) Sara Palermo et al. HUMAN BRAIN MAPPING
- Medicine's inconvenient truth: the placebo and nocebo effect
- (2014) M. H. Arnold et al. INTERNAL MEDICINE JOURNAL
- Avoiding Nocebo Effects to Optimize Treatment Outcome
- (2014) Ulrike Bingel JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultation
- (2014) Dimos D. Mitsikostas et al. NEUROLOGICAL SCIENCES
- Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis
- (2014) Paul Emery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway
- (2014) Fabrizio Benedetti et al. PAIN
- Use of ClinicalTrials.gov to Estimate Condition-Specific Nocebo Effects and Other Factors Affecting Outcomes of Analgesic Trials
- (2013) M. Soledad Cepeda et al. JOURNAL OF PAIN
- Using Sherlock and ClinicalTrials.gov Data to Understand Nocebo Effects and Adverse Event Dropout Rates in the Placebo Arm
- (2013) M. Soledad Cepeda et al. JOURNAL OF PAIN
- Nocebo hyperalgesia induced by social observational learning
- (2013) Elisabeth Vögtle et al. PAIN
- Saying Things the “Right” Way: Avoiding “Nocebo” Effects and Providing Full Informed Consent
- (2012) Jeremy Howick AMERICAN JOURNAL OF BIOETHICS
- To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent
- (2012) Rebecca Erwin Wells et al. AMERICAN JOURNAL OF BIOETHICS
- Individual magnetic resonance imaging and radiographic features of knee osteoarthritis in subjects with unilateral knee pain: The Health, Aging, and Body Composition Study
- (2012) M. K. Javaid et al. ARTHRITIS AND RHEUMATISM
- Development of the Stanford Expectations of Treatment Scale (SETS): A tool for measuring patient outcome expectancy in clinical trials
- (2012) Jarred Younger et al. Clinical Trials
- Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes
- (2012) Luana Colloca et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects
- (2012) Kate Faasse et al. PSYCHOSOMATIC MEDICINE
- Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre–post observational study
- (2012) Kate Faasse et al. BMJ Open
- Mechanisms of Chronic Pain in Osteoarthritis
- (2012) Hans-Georg Schaible Current Rheumatology Reports
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Unawareness of deficits in Alzheimer’s disease: role of the cingulate cortex
- (2011) Martina Amanzio et al. BRAIN
- Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches
- (2011) Dimos D Mitsikostas et al. CEPHALALGIA
- Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials
- (2011) W Rief et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nocebo in Headaches: Implications for Clinical Practice and Trial Design
- (2011) Dimos D. Mitsikostas Current Neurology and Neuroscience Reports
- Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice
- (2011) D. D. Mitsikostas et al. EUROPEAN JOURNAL OF NEUROLOGY
- Induction of nocebo and placebo effects on itch and pain by verbal suggestions
- (2011) Antoinette I.M. van Laarhoven et al. PAIN
- The Nocebo Effect and Its Relevance for Clinical Practice
- (2011) Luana Colloca et al. PSYCHOSOMATIC MEDICINE
- Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool
- (2010) John Axford et al. CLINICAL RHEUMATOLOGY
- Nonspecific side effects of oral contraceptives: nocebo or noise?
- (2010) David A. Grimes et al. CONTRACEPTION
- Insular Cortex Activity Is Associated with Effects of Negative Expectation on Nociceptive Long-Term Habituation
- (2010) R. Rodriguez-Raecke et al. JOURNAL OF NEUROSCIENCE
- Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans
- (2010) Irene Tracey NATURE MEDICINE
- Predicting Value of Pain and Analgesia: Nucleus Accumbens Response to Noxious Stimuli Changes in the Presence of Chronic Pain
- (2010) Marwan N. Baliki et al. NEURON
- Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors
- (2010) Fabrizio Benedetti et al. PSYCHOPHARMACOLOGY
- Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines
- (2010) Yvonne Nestoriuc et al. ARTHRITIS CARE & RESEARCH
- Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients
- (2009) Stephen E. Gwilym et al. ARTHRITIS AND RHEUMATISM
- Gender and the nocebo response following conditioning and expectancy
- (2009) Sibylle Klosterhalfen et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- A systematic review of adverse events in placebo groups of anti-migraine clinical trials
- (2009) Martina Amanzio et al. PAIN
- Placebo analgesia induced by social observational learning
- (2009) Luana Colloca et al. PAIN
- Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
- (2009) Johann D. Ringe et al. RHEUMATOLOGY INTERNATIONAL
- The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
- (2008) W Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
- (2008) G Wells et al. ANNALS OF THE RHEUMATIC DISEASES
- A Functional Magnetic Resonance Imaging Study on the Neural Mechanisms of Hyperalgesic Nocebo Effect
- (2008) J. Kong et al. JOURNAL OF NEUROSCIENCE
- The role of learning in nocebo and placebo effects
- (2008) L. Colloca et al. PAIN
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
- (2008) Ted J Kaptchuk et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started